link
Bookmarks
Corpus Callosum Mass
Karen L. Salzman, MD
To access 4,300 diagnoses written by the world's leading experts in radiology, please log in or subscribe.Subscribe

DIFFERENTIAL DIAGNOSIS

    ESSENTIAL INFORMATION

    • Helpful Clues for Common Diagnoses

      • Helpful Clues for Less Common Diagnoses

        • Helpful Clues for Rare Diagnoses

          • Alternative Differential Approaches

            Selected References

            1. Dibble EH et al: Toxoplasmosis versus lymphoma: cerebral lesion characterization using DSC-MRI revisited. Clin Neurol Neurosurg. 152:84-89, 2017
            2. Godi C et al: High b-value diffusion-weighted imaging in progressive multifocal leukoencephalopathy in HIV patients. Eur Radiol. ePub, 2017
            3. Igra MS et al: Multiple sclerosis update: use of MRI for early diagnosis, disease monitoring and assessment of treatment related complications. Br J Radiol. 20160721, 2017
            4. Lin X et al: Diagnostic accuracy of T1-weighted dynamic contrast-enhanced-MRI and DWI-ADC for differentiation of glioblastoma and primary CNS lymphoma. AJNR Am J Neuroradiol. 38(3):485-491, 2017
            5. Starkey J et al: Cytotoxic lesions of the corpus callosum that show restricted diffusion: mechanisms, causes, and manifestations. Radiographics. 37(2):562-576, 2017
            6. Hodel J et al: Asymptomatic progressive multifocal leukoencephalopathy associated with natalizumab: diagnostic precision with MR imaging. Radiology. 278(3):863-72, 2016
            7. Wijburg MT et al: MRI criteria differentiating asymptomatic PML from new MS lesions during natalizumab pharmacovigilance. J Neurol Neurosurg Psychiatry. 87(10):1138-45, 2016
            8. Jordan JT et al: Magnetic resonance imaging observations in primary central nervous system lymphoma. JAMA Neurol. 71(7):918-9, 2014
            9. Garcia-Monco JC et al: Isolated and reversible lesions of the corpus callosum: a distinct entity. J Neuroimaging. 20(1):1-2, 2010
            Related Anatomy
            Loading...
            Related Differential Diagnoses
            Loading...
            References
            Tables

            Tables

            DIFFERENTIAL DIAGNOSIS

              ESSENTIAL INFORMATION

              • Helpful Clues for Common Diagnoses

                • Helpful Clues for Less Common Diagnoses

                  • Helpful Clues for Rare Diagnoses

                    • Alternative Differential Approaches

                      Selected References

                      1. Dibble EH et al: Toxoplasmosis versus lymphoma: cerebral lesion characterization using DSC-MRI revisited. Clin Neurol Neurosurg. 152:84-89, 2017
                      2. Godi C et al: High b-value diffusion-weighted imaging in progressive multifocal leukoencephalopathy in HIV patients. Eur Radiol. ePub, 2017
                      3. Igra MS et al: Multiple sclerosis update: use of MRI for early diagnosis, disease monitoring and assessment of treatment related complications. Br J Radiol. 20160721, 2017
                      4. Lin X et al: Diagnostic accuracy of T1-weighted dynamic contrast-enhanced-MRI and DWI-ADC for differentiation of glioblastoma and primary CNS lymphoma. AJNR Am J Neuroradiol. 38(3):485-491, 2017
                      5. Starkey J et al: Cytotoxic lesions of the corpus callosum that show restricted diffusion: mechanisms, causes, and manifestations. Radiographics. 37(2):562-576, 2017
                      6. Hodel J et al: Asymptomatic progressive multifocal leukoencephalopathy associated with natalizumab: diagnostic precision with MR imaging. Radiology. 278(3):863-72, 2016
                      7. Wijburg MT et al: MRI criteria differentiating asymptomatic PML from new MS lesions during natalizumab pharmacovigilance. J Neurol Neurosurg Psychiatry. 87(10):1138-45, 2016
                      8. Jordan JT et al: Magnetic resonance imaging observations in primary central nervous system lymphoma. JAMA Neurol. 71(7):918-9, 2014
                      9. Garcia-Monco JC et al: Isolated and reversible lesions of the corpus callosum: a distinct entity. J Neuroimaging. 20(1):1-2, 2010